5-Bromo-6-Thioureidoquinoxaline is a specialized brominated quinoxaline intermediate used in pharmaceutical and fine chemical research. The compound contains a quinoxaline heterocyclic core substituted with bromine and …
5-Bromo-6-Thioureidoquinoxaline is a specialized brominated quinoxaline intermediate used in pharmaceutical and fine chemical research. The compound contains a quinoxaline heterocyclic core substituted with bromine and a thioureido functional group, providing useful chemical functionality for further synthetic transformations. It is particularly associated with research and manufacturing processes involving quinoxaline-based pharmaceutical intermediates.
5-Bromo-6-Thioureidoquinoxaline has been described in published process literature as an intermediate in the preparation of brimonidine-related compounds. In documented chemistry, the compound can undergo further transformation to S-methyl derivatives and subsequent cyclization steps. This makes it a relevant intermediate for pharmaceutical process development, medicinal chemistry research, and specialty chemical synthesis.
Nexa Impex supplies 5-Bromo-6-Thioureidoquinoxaline for research, development, pharmaceutical intermediate, and specialty chemical requirements, subject to product availability and mutually agreed specifications. The product can be considered for laboratory-scale development as well as commercial procurement requirements where appropriate quality specifications, quantity, packaging, and documentation are established between the customer and supplier.
Nexa Impex focuses on quality-oriented sourcing, responsive customer support, flexible packaging, and supply coordination for pharmaceutical and specialty chemical customers. Relevant technical documentation such as COA, SDS/MSDS, specification information, and other applicable commercial documents can be provided subject to product availability and customer requirements.
5-Bromo-6-Thioureidoquinoxaline can be supplied in laboratory, sample, and bulk packaging configurations according to customer requirements. Packaging type, quantity, labeling, and shipment requirements can be discussed and finalized according to the intended application and commercial requirements.
Reference specification for 5-Bromo-6-Thioureidoquinoxaline — confirm current certificate of analysis against your target pharmacopoeia at enquiry.
| Parameter | Specification |
|---|---|
| Molecular Formula | C9H7BrN4S |
| Appearance | Solid |
| Molecular Weight | 283.12 g/mol |
Common questions from buyers evaluating 5-Bromo-6-Thioureidoquinoxaline sourcing from NexaImpex.